AAV Vector Integration Sites in Mouse Hepatocellular Carcinoma
暂无分享,去创建一个
Daniel G. Miller | Elizabeth M. Brunt | D. Russell | M. Sands | E. Brunt | Yi Li | Anthony Donsante | Carole Vogler | David W. Russell | Mark S. Sands | C. Vogler | A. Donsante | Yi Li
[1] C. Epstein,et al. Nuclear Ploidy in Mammalian Parenchymal Liver Cells , 1967, Nature.
[2] E. Furth,et al. Analysis of tumors arising in male B6C3F1 mice with and without AAV vector delivery to liver. , 2006, Molecular therapy : the journal of the American Society of Gene Therapy.
[3] Daniel G. Miller,et al. Large-Scale Analysis of Adeno-Associated Virus Vector Integration Sites in Normal Human Cells , 2005, Journal of Virology.
[4] Theresa A. Storm,et al. Large-Scale Molecular Characterization of Adeno-Associated Virus Vector Integration in Mouse Liver , 2005, Journal of Virology.
[5] A. Ferguson-Smith,et al. Epigenetic alteration at the DLK1-GTL2 imprinted domain in human neoplasia: analysis of neuroblastoma, phaeochromocytoma and Wilms' tumour , 2005, British Journal of Cancer.
[6] T. Flotte,et al. Observed incidence of tumorigenesis in long-term rodent studies of rAAV vectors , 2001, Gene Therapy.
[7] H. Okabe,et al. Imprinted DLK1 is a putative tumor suppressor gene and inactivated by epimutation at the region upstream of GTL2 in human renal cell carcinoma. , 2006, Human molecular genetics.